Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 9 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vera Therapeutics, Inc. | 3,429,927 | reported | 10 Feb 2022 | tx 1+333,333 |
| THRESHOLD PHARMACEUTICALS INC | 3,261,535 | reported | 21 Sept 2018 | tx 1+365,000 |
| COLLEGIUM PHARMACEUTICAL, INC | 2,276,222 | reported | 08 Dec 2017 | tx 2−1,000,000 |
| Inozyme Pharma, Inc. | 2,194,379 | reported | 28 Jul 2020 | tx 5+2,819,379−16,398,600 |
| ProNAi Therapeutics Inc | 175,000 | reported | 02 Feb 2022 | tx 1+175,000 |
| CORCEPT THERAPEUTICS INC | 133,539 | reported | 15 Dec 2016 | tx 11+7,056,548−1,102,162 |
| RxSight, Inc. | 85,183 | reported | 17 Jun 2026 | tx 43+3,173,939−4,978,946 |
| Ceribell, Inc. | 23,284 | reported | 02 Jun 2026 | tx 6+2,401,118−2,140,600 |
| Aimmune Therapeutics, Inc. | 16,651 | reported | 22 Feb 2018 | tx 3+87,879 |
| Venus Concept Inc. | 8,650 | reported | 07 Nov 2019 | tx 4+3,692,070 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jun 2026 | GRANT_AWARD | RxSight, Inc. | 37,037 | — | |
| 02 Jun 2026 | GRANT_AWARD | Ceribell, Inc. | 7,838 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | Ceribell, Inc. | 8,828 | 0.00 USD | |
| 03 Jun 2025 | GRANT_AWARD | RxSight, Inc. | 10,752 | — | |
| 15 Oct 2024 | CONVERSION | Ceribell, Inc. | 2,140,600 | — | |
| 15 Oct 2024 | PURCHASE | Ceribell, Inc. | 237,234 | 17.00 USD | |
| 11 Oct 2024 | GRANT_AWARD | Ceribell, Inc. | 6,618 | 0.00 USD | |
| 15 Oct 2024 | CONVERSION | Ceribell, Inc. | 2,140,600 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | RxSight, Inc. | 2,554 | — | |
| 17 May 2024 | PURCHASE | RxSight, Inc. | 5,000 | 61.09 USD | |
| 14 Feb 2024 | PURCHASE | RxSight, Inc. | 4,000 | 51.29 USD | |
| 12 Feb 2024 | PURCHASE | RxSight, Inc. | 4,000 | 50.38 USD | first after silence |
| 30 Nov 2023 | OTHER | RxSight, Inc. | 1,617 | 0.00 USD | |
| 30 Nov 2023 | OTHER | RxSight, Inc. | 445,400 | 0.00 USD | |
| 29 Nov 2023 | SALE | RxSight, Inc. | 349,245 | 29.77 USD | |
| 28 Nov 2023 | SALE | RxSight, Inc. | 145,068 | 29.62 USD | |
| 30 Nov 2023 | OTHER | RxSight, Inc. | 693 | 0.00 USD | |
| 14 Nov 2023 | SALE | RxSight, Inc. | 100,000 | 27.13 USD | |
| 15 Nov 2023 | SALE | RxSight, Inc. | 400,000 | 27.20 USD | |
| 07 Sept 2023 | SALE | RxSight, Inc. | 19,967 | 30.10 USD | |
| 08 Sept 2023 | SALE | RxSight, Inc. | 10,033 | 30.25 USD | |
| 11 Sept 2023 | SALE | RxSight, Inc. | 2,950 | 30.01 USD | |
| 25 Aug 2023 | SALE | RxSight, Inc. | 16,208 | 29.25 USD | |
| 24 Aug 2023 | OTHER | RxSight, Inc. | 416 | 0.00 USD | |
| 24 Aug 2023 | OTHER | RxSight, Inc. | 970 | 0.00 USD |
5 purchases reported after at least 12 months of silence — most recent on 12 Feb 2024.